Wegovy needle size: what the pen uses and why it matters

You've just opened the box and you're staring at the pen

Most people picking up a Wegovy pen for the first time have the same thought: is this going to hurt? It is a fair question, and the answer is shaped almost entirely by the needle specification. At 4 mm in length and 32 gauge, the needle is shorter than a standard insulin needle and finer than most blood-test needles, and you can read more about what Wegovy needles size means in practice if you want the full breakdown before your first injection. In practice, the vast majority of people describe the sensation as a brief, mild sting (comparable to a small scratch) that passes within seconds.

The needle is concealed inside the pen body until you press the injector against your skin and activate it. There is no separate needle to screw on, no cap to remove with your fingers, and no sharp exposed tip sitting in a sharps bin between uses. After the injection, the mechanism shields the needle automatically. That covered-needle design is one reason the pen suits people who are nervous around needles; you genuinely never have to look at it if you would rather not.

The NHS semaglutide medicines page covers injection technique alongside the full side-effect and storage information, it is worth bookmarking alongside the Patient Information Leaflet that comes in the box, both of which go into more detail than any article can.

If you want a closer look at what the pen assembly involves before committing, our page on the Wegovy pen and needle walks through the physical components step by step.

Why a 4 mm needle is long enough, and why gauge matters more than length

Wegovy is administered subcutaneously: into the fatty tissue that sits just below the skin, not into muscle. Subcutaneous injections do not require length to reach a vein or deep tissue; they need only to clear the skin layer, which is typically 1.5–3 mm thick even in lean individuals. A 4 mm needle reliably reaches the subcutaneous layer across almost every body type without overshooting into muscle, which would affect absorption and increase discomfort.

Gauge describes the needle's diameter. A higher gauge number means a narrower needle. At 32 gauge, the Wegovy needle is narrow enough that the flow of the small-volume dose (semaglutide solutions are measured in tiny fractions of a millilitre) causes no practical resistance and leaves a skin entry point small enough to close almost instantly. The combination of short length and fine gauge is why subcutaneous GLP-1 injections have a markedly different feel from, say, an intramuscular flu jab.

Technique adjustments do matter even with a short needle. Pinching a fold of skin at the injection site before pressing the pen down is recommended for people with less subcutaneous tissue, it ensures the needle lands in fat rather than muscle. Hold the pen in place for a full ten seconds after the click; releasing early can mean some of the dose escapes through the puncture site rather than dispersing into the tissue. Your prescriber or pharmacist at the start of treatment is the right person to confirm your specific technique, because body composition genuinely varies. Our dedicated page on how long a Wegovy needle is explains why that 4 mm figure is sufficient across different body types.

For context on how this compares with other injectable weight-loss medicines, our overview of semaglutide needle size sets out the technical details side by side.

Rotating sites and looking after your skin over weeks of treatment

Wegovy is a once-weekly injection. That means the same patch of subcutaneous tissue is being asked to absorb a dose every seven days, and if you return to the exact same point repeatedly, you can develop lipohypertrophy, a thickening or hardening of the fatty tissue that not only feels uncomfortable but can slow how reliably the medicine is absorbed. Rotating your site each week is one of those small habits that pays off quietly over months of treatment.

The three licensed sites are the abdomen (at least a couple of centimetres from the navel), the outer thigh, and the upper arm. Many people find the abdomen the most straightforward to self-inject, particularly early in treatment, because it is easy to pinch and easy to see. Some find the thigh more comfortable when wearing certain clothing. The upper arm is the most awkward for solo self-injection, a household member or carer usually helps with that site.

Clean the skin with an alcohol swab before each injection and let it dry fully before pressing the pen. If you need alcohol swabs, we stock them in our pharmacy and they can be ordered alongside your treatment. Used pens go into a sharps bin, not the household bin, your local council or community pharmacy can advise on clinical waste collection, or you can order a dedicated sharps container if you haven't already sorted one.

One thing our prescribers hear regularly: patients who started treatment just before a bank holiday or summer holiday worried about storage. The pen is designed for refrigeration at 2–8°C, but there is a limited window for room-temperature storage when you are travelling. The exact duration is in the Patient Information Leaflet, check it before you pack.

If questions come up about site reactions, bruising, or anything else during treatment, our clinical team is reachable seven days a week. You can read more about how we work on our about us page, or see the FAQs for common aftercare questions.

What if you are considering Wegovy for the first time?

Knowing the needle is small and the pen is straightforward removes one of the most common early hesitations, but it does not substitute for clinical assessment. Wegovy (semaglutide 2.4 mg and, as of April 2026, up to 7.2 mg) is a prescription-only medicine licensed for weight management in adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition. A prescriber decides whether it is appropriate for you based on your full health picture, not just your BMI.

If you are weighing up the injectable route against other options, our guide to weight-loss treatment options covers the licensed choices available in the UK, and our page on Wegovy goes into the clinical evidence in more detail, including the results from the STEP 1 trial published in the New England Journal of Medicine.

Cost is often part of the conversation. Wegovy is not currently available on the NHS outside specialist weight management services, so most people access it privately. Our Wegovy cost page sets out what private treatment typically involves financially and what a single transparent price does and does not include. Price matters, but for a prescription medicine, the clinical infrastructure around it matters more.

If you are ready to move forward, speak to our prescribers, the consultation is free, reviewed the same day by a real clinician, and there is no obligation.